跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 359 条关于
“FNZ”
全部
359
临床试验
255
药物
77
机构
14
资讯
13
5个月前
NIH Researchers Develop Novel Opioid DFNZ with Potent Pain Relief and Reduced Addiction Risk
去年
New Zealand to Fund Osimertinib, Trastuzumab Deruxtecan, Palivizumab, and Budesonide/Glycopyrronium/Formoterol
去年
Inozyme's INZ-701 Shows Promise in ENPP1 and ABCC6 Deficiencies
9个月前
BioMarin Awaits Pivotal INZ-701 Trial Results Following $270M Inozyme Acquisition
2年前
Ferrer's FNP-223 Enters Phase II Trial for Progressive Supranuclear Palsy
去年
Inozyme's INZ-701 Shows Promise in ENPP1 Deficiency Trial with Sustained Phosphate Increases
3个月前
FN1+ Macrophages Drive Aggressive Sarcomatoid Differentiation and Immunotherapy Resistance in Renal Cell Carcinoma
去年
Neuren Pharmaceuticals Secures US Patent for NNZ-2591 in Pitt Hopkins Syndrome Treatment
11个月前
Neuren Pharmaceuticals Receives FDA Fast Track Designation for NNZ-2591 in Rare Neurological Syndromes
11个月前
Ferrer Completes Early Enrollment for Phase II PSP Trial Testing Novel OGA Inhibitor FNP-223
第 1 页,共 2 页
上一页
下一页